As of December 2024, Hybio Pharmaceutical has a market cap of $1.56B. This makes Hybio Pharmaceutical the world's 6205th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.29B | -21.50% |
2023 | $1.65B | -22.75% |
2022 | $2.13B | 39.41% |
2021 | $1.53B | 89.62% |
2020 | $807.35M | 14.66% |
2019 | $704.15M | -37.90% |
2018 | $1.13B | -42.63% |
2017 | $1.98B | -9.45% |
2016 | $2.18B | -27.00% |
2015 | $2.99B | 82.44% |
2014 | $1.64B | 27.36% |
2013 | $1.29B | 207.47% |
2012 | $418.55M | - |